New Investigator Awards
2019 (Cycle 30)
| Novel Immunotherapeutics for Cigarette-Smoking Associated Acute Myeloid Leukemia | 2019 (Cycle 30) | $990,000 |
| University of Southern California | Cancer | |
2019 (Cycle 29)
| Impact of splicing factor mutations in the context of tobacco exposure in lung cancer | 2019 (Cycle 29) | $736,710 |
| University of California, Santa Cruz | Cancer | |
| Community College Smoke free Policies: Disparities, Contexts and Strategies | 2019 (Cycle 29) | $948,641 |
| Public Health Institute | State and Local Tobacco Control Policy Research | |
| Cigarette smoke effects on nitric oxide-dependent muscle regeneration | 2019 (Cycle 29) | $720,338 |
| University of California, San Diego | Environmental Exposure/Toxicology | |
| Elucidating the genetic basis of nicotine dependence by using electronic health records | 2019 (Cycle 29) | $743,841 |
| University of California, San Diego | Neuroscience of Nicotine Addiction and Treatment | |
| Impact of Chronic Cannabis Exposure on Metabolic Health and Disease | 2019 (Cycle 29) | $743,386 |
| University of California, Riverside | Cardiovascular and Cerebrovascular Disease | |
2019 (Cycle 28)
| Impact of vape pen placement in music videos on young adults | 2019 (Cycle 28) | $961,915 |
| University of Southern California | State and Local Tobacco Control Policy Research | |
| Multiethnic Risk for Lung Disease: Genetics and Smoking | 2019 (Cycle 28) | $990,000 |
| University of Southern California | Pulmonary Disease | |
| Tobacco Posts Social Media of Vulnerable, At-Risk Groups | 2019 (Cycle 28) | $748,149 |
| University of California, San Diego | Tobacco-Use Prevention and Cessation | |
2018 (Cycle 27)
| Multilevel Study of Lung Cancer Screening Guidelines Implementation | 2018 (Cycle 27) | $886,353 |
| Palo Alto Medical Foundation Research Institute | Cancer | |
| Oncogenic reprogramming of protein translation by DDX3 inact | 2018 (Cycle 27) | $748,146 |
| University of California, San Francisco | Cancer | |
| Modulation of hedgehog signaling in tobacco-related emphysema | 2018 (Cycle 27) | $734,678 |
| University of California, San Francisco | Pulmonary Disease | |
| Tackling Stem-Like Cells in Tobacco Smoke-Mediated Cancer Ma | 2018 (Cycle 27) | $750,000 |
| University of California, Davis | Cancer | |
2011 (Cycle 20)
| New Diagnosis of Bladder Cancer: Smokers Opportunity to Quit | 2011 (Cycle 20) | $269,936 |
| University of California, Los Angeles | Cancer | |
| Role of PHLPP1 in Astrocytes and Stroke | 2011 (Cycle 20) | $300,000 |
| University of California, San Diego | Cardiovascular Disease | |
| Snail-Dependent Malignant Conversion of Airway Epithelium | 2011 (Cycle 20) | $266,934 |
| University of California, Los Angeles | Cancer | |
| Role of mGluR7 in nicotine dependence | 2011 (Cycle 20) | $270,000 |
| University of California, San Diego | Nicotine Dependence | |
| Dietary effects on tobacco-related lung cancer | 2011 (Cycle 20) | $270,000 |
| University of California, Berkeley | Cancer | |
| Indoor chemistry of secondhand and thirdhand smoke | 2011 (Cycle 20) | $271,559 |
| Lawrence Berkeley National Laboratory | General Biomedical Science | |
2010 (Cycle 19)
| Multiple Salivary Biomarkers for Lung Cancer Detection | 2010 (Cycle 19) | $241,103 |
| University of California, Los Angeles | Cancer | |
| Effects of Resistance Training on Tobacco-Related CVD Risk | 2010 (Cycle 19) | $270,000 |
| University of California, Los Angeles | Cardiovascular Disease | |
| Neurobiology of Cigarette Craving in Adolescent Smokers | 2010 (Cycle 19) | $266,435 |
| University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
| Prenatal Toxicity of Traditional and Harm Reducation Tobacco | 2010 (Cycle 19) | $314,772 |
| University of California, Riverside | General Biomedical Science | |
| Nicotinic receptor-lynx interactions | 2010 (Cycle 19) | $278,797 |
| California Institute of Technology | Nicotine Dependence | |
| Pulmonary Rehabilitation in Sleep Disorders affecting COPD | 2010 (Cycle 19) | $270,000 |
| University of California, San Diego | Pulmonary Disease | |
| High resolution imaging & ablation for smoke induced cancer | 2010 (Cycle 19) | $264,219 |
| University of California, Irvine | Cancer | |
| Characterization of Platelet Thromboxane A2 Receptors | 2010 (Cycle 19) | $277,422 |
| Western University of Health Sciences | Cardiovascular Disease | |
2009 (Cycle 18)
| Novel treatments for COPD with Statins | 2009 (Cycle 18) | $269,523 |
| University of California, Davis | Pulmonary Disease | |
| Impulsivity as a risk factor for nicotine dependence | 2009 (Cycle 18) | $270,000 |
| University of California, San Diego | Nicotine Dependence | |
| Mechanistic studies of secondhand-smoke carcinogenicity | 2009 (Cycle 18) | $12,610 |
| University of Southern California | Cancer | |
| Mechanistic studies of secondhand-smoke carcinogenicity | 2009 (Cycle 18) | $278,795 |
| Beckman Research Institute of the City of Hope | Cancer | |
| Prenatal Nicotine Exposure and Vascular Programming | 2009 (Cycle 18) | $289,840 |
| Loma Linda University | Nicotine Dependence | |
| Pharmacological Interventions for Heavy Drinking Smokers | 2009 (Cycle 18) | $283,371 |
| University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
| Impact of tobacco-smoke on apolipoprotein exchangeability | 2009 (Cycle 18) | $324,000 |
| Children's Hospital Oakland Research Institute | Cardiovascular Disease | |
| NGAL-dependent Apoptosis Resistance in NSCLC | 2009 (Cycle 18) | $180,000 |
| University of California, Los Angeles | Cancer | |
2008 (Cycle 17)
| Interaction of LDL receptor family members with ligands | 2008 (Cycle 17) | $266,162 |
| Children's Hospital Oakland Research Institute | Cardiovascular Disease | |
| Genetics and Impulsivity in Smoking Initiation | 2008 (Cycle 17) | $282,860 |
| Veterans Medical Research Foundation | Nicotine Dependence | |
| Transcription Regulation of Inflammation by Glucocorticoids | 2008 (Cycle 17) | $270,000 |
| University of California, Berkeley | Pulmonary Disease | |
| Community and Family Context of Teen Smoking | 2008 (Cycle 17) | $270,000 |
| University of California, Los Angeles | Public Health, Public Policy, and Economics | |
2007 (Cycle 16)
| Oxylipin Mediators Prevent Smoke-Induced Lung Inflammation | 2007 (Cycle 16) | $260,203 |
| University of California, Davis | Pulmonary Disease | |
| Engineering Salmonella for lung cancer therapy | 2007 (Cycle 16) | $187,550 |
| Sidney Kimmel Cancer Center | Cancer | |
| Engineering Salmonella for lung cancer therapy | 2007 (Cycle 16) | $104,050 |
| The Burnham Institute for Medical Research | Cancer | |
| Secondhand Smoke and Nontuberculous Mycobacterial Infection | 2007 (Cycle 16) | $270,000 |
| University of California, San Diego | Epidemiology | |
| Targeting the epithelial-mesenchymal transition in HNSCC | 2007 (Cycle 16) | $270,000 |
| University of California, Los Angeles | Cancer | |
| 50000 Fold Signal Enhancement for Imaging Vulnerable Plaque | 2007 (Cycle 16) | $213,845 |
| Huntington Medical Research Institute | Cardiovascular Disease | |
2006 (Cycle 15)
| African Americans: NRT or Alternative Medicine for Cessation | 2006 (Cycle 15) | $285,000 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Modeling ETS Exposure and Dose Using PDA E-Diaries | 2006 (Cycle 15) | $245,214 |
| San Diego State University Research Foundation | Epidemiology | |
| Nicotinic Regulation of GABAergic Signaling | 2006 (Cycle 15) | $70,120 |
| University of California, San Diego | Nicotine Dependence | |
| Stem cell regeneration of the airway: effects of smoke | 2006 (Cycle 15) | $269,443 |
| University of California, Davis | Pulmonary Disease | |
| Tobacco Industry Political Strategies After the 1998 MSA | 2006 (Cycle 15) | $269,000 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Tobacco GeneûEnvironment Interactions & Minority Asthmatics | 2006 (Cycle 15) | $299,500 |
| University of California, San Francisco | Pulmonary Disease | |
2005 (Cycle 14)
| Skeletal muscle structure and function in mice lacking VEGF | 2005 (Cycle 14) | $284,491 |
| University of California, San Diego | Pulmonary Disease | |
| Activation of Bnip3 in tobacco-induced heart disease | 2005 (Cycle 14) | $134,074 |
| Scripps Research Institute | Cardiovascular Disease | |
| Activation of Bnip3 in tobacco-induced heart disease | 2005 (Cycle 14) | $155,791 |
| San Diego State University Research Foundation | Cardiovascular Disease | |
| Do receptors mediate the effects of nicotine on anxiety? | 2005 (Cycle 14) | $291,060 |
| Salk Institute for Biological Studies | Nicotine Dependence | |
| Tobacco, acculturation and gastric cancer among Hispanics | 2005 (Cycle 14) | $179,367 |
| University of California, Davis | Epidemiology | |
| Water pipe use, SHS exposure & home policy in Arab Americans | 2005 (Cycle 14) | $323,068 |
| San Diego State University Research Foundation | Epidemiology | |
2004 (Cycle 13)
| Smoking and genes as determinants of SLE and RA serverity | 2004 (Cycle 13) | $52,662 |
| University of California, San Francisco | Epidemiology | |
| Curriculum for treating nicotine dependence in psychiatry | 2004 (Cycle 13) | $269,500 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Pulmonary function and genetic variation in smoke metabolism | 2004 (Cycle 13) | $23,693 |
| University of California, San Francisco | Epidemiology | |
| Regulation of a novel airway glandular mucin by smoke | 2004 (Cycle 13) | $126,126 |
| University of California, Davis | Pulmonary Disease | |
| Genomics & transcriptome of oral precncr prgrssion in smkers | 2004 (Cycle 13) | $189,541 |
| University of California, Los Angeles | Epidemiology | |
| Tobacco industry use of diet and obesity issues | 2004 (Cycle 13) | $267,526 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
2003 (Cycle 12)
| Smoking-related changes in LDL and atherosclerosis | 2003 (Cycle 12) | $269,500 |
| University of California, San Diego | Cardiovascular Disease | |
| Neuropharmacology of nicotine relapse | 2003 (Cycle 12) | $149,175 |
| Cedars-Sinai Medical Center | Nicotine Dependence | |
| The role of hCDC4 regulation of cyclin E in lung cancer | 2003 (Cycle 12) | $517,032 |
| Sidney Kimmel Cancer Center | Cancer | |
| Reactivity of surface nicotine towards indoor ozone | 2003 (Cycle 12) | $448,132 |
| Lawrence Berkeley National Laboratory | General Biomedical Science | |
| Influences that promote ethnic disparities in smoking | 2003 (Cycle 12) | $269,971 |
| University of California, San Diego | Public Health, Public Policy, and Economics | |
| Peripheral mechanisms of oral cancer pain in a mouse model | 2003 (Cycle 12) | $265,332 |
| University of California, San Francisco | Cancer | |
| Ethnic and gender variation in nicotine detoxification | 2003 (Cycle 12) | $424,142 |
| SRI International | Epidemiology | |
| The effect of nicotine on brain activity & neurocognition in schizophrenia | 2003 (Cycle 12) | $167,964 |
| University of California, Irvine | Nicotine Dependence | |
| Targeting Hypoxia-inducible Factor to Treat Lung Cancer | 2003 (Cycle 12) | $509,490 |
| The Burnham Institute for Medical Research | Cancer | |
2002 (Cycle 11)
| Modeling sleep disturbance during nicotine withdrawal | 2002 (Cycle 11) | $424,344 |
| SRI International | Nicotine Dependence | |
| Involvement of PI3K pathway in bladder cancer invasion | 2002 (Cycle 11) | $224,984 |
| University of California, Davis | Cancer | |
| MCP-1 and TGFb in pulmonary emphysema | 2002 (Cycle 11) | $78,241 |
| University of California, San Francisco | Pulmonary Disease | |
| Enzymatic targets for anticancer therapy | 2002 (Cycle 11) | $267,304 |
| J. David Gladstone Institutes | Cancer | |
2001 (Cycle 10)
| The role of P450s in tobacco-mediated lung cancer | 2001 (Cycle 10) | $147,858 |
| La Jolla Institute for Molecular Medicine | Cancer | |
| COPD: oxygen transport and metabolism in skeletal muscle | 2001 (Cycle 10) | $224,500 |
| University of California, San Diego | Pulmonary Disease | |
| Lung cancer therapy with in vivo-generated dendritic cells | 2001 (Cycle 10) | $225,000 |
| University of California, Los Angeles | Cancer | |
| The role of P450s in tobacco-mediated lung cancer | 2001 (Cycle 10) | $295,815 |
| California Toxicology Research Institute | Cancer | |
| Assessing nicotine relapse in a mouse model | 2001 (Cycle 10) | $183,804 |
| SRI International | Nicotine Dependence | |
| Nicotinic receptors & synaptic aging | 2001 (Cycle 10) | $224,973 |
| University of California, San Diego | Nicotine Dependence | |
| Remnant lipoproteins, apolipoprotein E4 and atherosclerosis | 2001 (Cycle 10) | $400,500 |
| J. David Gladstone Institutes | Cardiovascular Disease | |
| Deposition of inhaled carcinogens in ETS | 2001 (Cycle 10) | $210,446 |
| University of California, Irvine | General Biomedical Science | |
| Effects of tobacco smoke on airway bactericidal activity | 2001 (Cycle 10) | $87,079 |
| University of California, Davis | Pulmonary Disease | |
| Effect of nicotine on bone marrow cells | 2001 (Cycle 10) | $520,381 |
| La Jolla Institute for Molecular Medicine | Cardiovascular Disease | |
| Pathways of catabolism of oxidized phospholipids | 2001 (Cycle 10) | $225,000 |
| University of California, San Diego | Cardiovascular Disease | |
2000 (Cycle 9)
| To identify Egr-1 target genes important in pulmonary disease | 2000 (Cycle 9) | $430,539 |
| The Burnham Institute for Medical Research | Pulmonary Disease | |
| Nicotine & its metabolites: apoptosis in developing neurons | 2000 (Cycle 9) | $412,200 |
| Human BioMolecular Research Institute | General Biomedical Science | |
| Vascular endothelial growth factor receptor signaling | 2000 (Cycle 9) | $224,500 |
| University of California, San Francisco | Cardiovascular Disease | |
| Regulation of cytokine production in pulmonary inflammation | 2000 (Cycle 9) | $93,268 |
| University of California, San Diego | Pulmonary Disease | |
| Nitric oxide-dependent cell signaling in vascular cells | 2000 (Cycle 9) | $149,557 |
| University of California, San Diego | Cardiovascular Disease | |
| New therapy for lung cancer using radioiodide | 2000 (Cycle 9) | $225,000 |
| University of California, Los Angeles | Cancer | |
| Prospective relationship between risk perception & teen toba | 2000 (Cycle 9) | $224,884 |
| University of California, San Francisco | Epidemiology | |
| Understanding and preventing college smoking | 2000 (Cycle 9) | $122,377 |
| University of Southern California | Epidemiology | |
1999 (Cycle 8)
| Effects of exposure to secondhand smoke | 1999 (Cycle 8) | $194,404 |
| Kaiser Foundation Research Institute | Epidemiology | |
| Activation of NF-kB by cigarette smoke | 1999 (Cycle 8) | $224,217 |
| University of California, Davis | Pulmonary Disease | |
| Skeletal muscle structure and function in COPD | 1999 (Cycle 8) | $224,842 |
| University of California, San Diego | Pulmonary Disease | |
| Carbon monoxide as a modulator of myocardial function | 1999 (Cycle 8) | $225,000 |
| University of California, Davis | Cardiovascular Disease | |
| Smoking & depression in Chinese vs. non-Chinese | 1999 (Cycle 8) | $225,000 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Regulation of lung inflammation by the LTC4 synthase pathway | 1999 (Cycle 8) | $225,000 |
| University of California, San Diego | Pulmonary Disease | |
| Targeted blood clotting therapy for lung cancer | 1999 (Cycle 8) | $350,851 |
| University of Southern California | Cancer | |
1998 (Cycle 7)
| An economic analysis of factors influencing teen smoking | 1998 (Cycle 7) | $221,497 |
| University of California, San Diego | Public Health, Public Policy, and Economics | |
| Predictors of adolescent smoking initiation and cessation | 1998 (Cycle 7) | $224,374 |
| University of California, San Diego | Epidemiology | |
| Susceptibility to smoking among adolescent never smokers | 1998 (Cycle 7) | $301,356 |
| University of Southern California | Epidemiology | |
| Global determinants of tobacco use onset in diverse youth | 1998 (Cycle 7) | $280,749 |
| Education Training and Research Associates, Inc. | Epidemiology | |
| Neuroendocrine responses to nicotine: a physiologic probe | 1998 (Cycle 7) | $225,000 |
| University of California, San Francisco | Nicotine Dependence | |
| Brain metabolic changes with cigarette craving | 1998 (Cycle 7) | $250,850 |
| Brentwood Biomedical Research Institute | Nicotine Dependence | |
| How does cardiac fuel metabolism influence heart disease? | 1998 (Cycle 7) | $262,005 |
| J. David Gladstone Institutes | Cardiovascular Disease | |
1997 (Cycle 6)
| Acculturation & cigarette smoking among Asian-Americans | 1997 (Cycle 6) | $244,715 |
| University of Southern California | Epidemiology | |
| Alterations in gene expression after tobacco smoke exposure | 1997 (Cycle 6) | $216,612 |
| University of California, Davis | Pulmonary Disease | |
| Brain wave assessment of tobacco cessation readiness | 1997 (Cycle 6) | $115,487 |
| Scripps Research Institute | Nicotine Dependence | |
| The biological basis of nicotine addiction | 1997 (Cycle 6) | $224,949 |
| University of California, Riverside | Nicotine Dependence | |
| Cigar use prevalence: social and media determinants | 1997 (Cycle 6) | $318,750 |
| San Diego State University Research Foundation | Public Health, Public Policy, and Economics | |
| Effects of tobacco on inflammatory cell responses | 1997 (Cycle 6) | $223,585 |
| University of California, Davis | Pulmonary Disease | |
| Effect of sidestream smoke on lung injury and repair | 1997 (Cycle 6) | $214,070 |
| University of California, Davis | Pulmonary Disease | |
| Motivational interviewing to prevent postpartum relapse | 1997 (Cycle 6) | $282,502 |
| Kaiser Foundation Research Institute | Tobacco-Use Prevention and Cessation | |
| Noninvasive imaging of early atherosclerosis | 1997 (Cycle 6) | $101,923 |
| University of California, San Diego | Cardiovascular Disease | |
| Interdependence - smoking behavior & mood in natural setting | 1997 (Cycle 6) | $222,843 |
| University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
| Role of viral-derived genes in lung cancer | 1997 (Cycle 6) | $375,800 |
| Sidney Kimmel Cancer Center | Cancer | |
1995 (Cycle 4)
| Functional Antagonists of Nicotine | 1995 (Cycle 4) | $236,936 |
| Northern California Institute for Research & Education | General Biomedical Science | |
| Involvement of Lipids in Smoking-induced LDL Atherogenicity | 1995 (Cycle 4) | $175,844 |
| Children's Hospital Oakland Research Institute | Cardiovascular Disease | |
| Role of Protein Phosphatases in Lung Cancer | 1995 (Cycle 4) | $363,234 |
| University of Southern California | Cancer | |
| Gene Augmentation Therapy for Tobacco Induced Emphysema | 1995 (Cycle 4) | $224,786 |
| University of California, Davis | Pulmonary Disease | |
| Nicotine & Neuroendocrine Cell Signalling in Fetal Lung | 1995 (Cycle 4) | $349,873 |
| University of Southern California | Pulmonary Disease | |
| Vitronectin in Cardiovascular Disease | 1995 (Cycle 4) | $352,644 |
| Scripps Research Institute | Cardiovascular Disease | |
1994 (Cycle 3)
| p53 Mutations in Sporadic & Familial Childhood Tumors | 1994 (Cycle 3) | $213,407 |
| University of California, Davis | Cancer | |
| Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis | 1994 (Cycle 3) | $43,318 |
| University of California, San Francisco | Cancer | |
| Effects of Nicotine on Pulmonary Neuroendocrine Cell Growth | 1994 (Cycle 3) | $377,973 |
| Doheny Eye Institute | General Biomedical Science | |
| Angiotensin II Regulation of the Cardiac Fibroblast | 1994 (Cycle 3) | $219,533 |
| University of California, San Diego | Cardiovascular Disease | |
| Direct Analysis of Lung Cancer Development & Progression | 1994 (Cycle 3) | $336,973 |
| University of Southern California | Cancer | |
| Mechanisms of Atherogenesis:Role of Shear Stress & Tobacco | 1994 (Cycle 3) | $314,974 |
| Stanford University | Cardiovascular Disease | |
| Addressing Substance Abusers Who Also Smoke | 1994 (Cycle 3) | $270,931 |
| Northern California Institute for Research & Education | Tobacco-Use Prevention and Cessation | |
| Environmental Tobacco Smoke & Epithelial Barrier Function | 1994 (Cycle 3) | $221,949 |
| University of California, Davis | Pulmonary Disease | |
| Nicotinic Receptor Biology in CNS Neurons: An in vitro Model | 1994 (Cycle 3) | $225,000 |
| University of California, San Diego | Nicotine Dependence | |
| Retinoblastoma Protein Dephosphorylation in Lung Cancer | 1994 (Cycle 3) | $250,223 |
| Childrens Hospital, Los Angeles | Cancer | |
| Animal Models of Human Risk from Environmental Tobacco Smoke | 1994 (Cycle 3) | $135,482 |
| University of California, Davis | Epidemiology | |
| Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis | 1994 (Cycle 3) | $175,409 |
| Stanford University | Cancer | |
| Tobacco Use Among Hispanics in California | 1994 (Cycle 3) | $138,919 |
| University of California, San Diego | Public Health, Public Policy, and Economics | |
| Political Activities of the Tobacco Industry in California | 1994 (Cycle 3) | $144,498 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Nicotine and Hemostatic Function of Brain Endothelium | 1994 (Cycle 3) | $342,880 |
| University of Southern California | Cardiovascular Disease | |
| Endothelial Barrier Injury by Tobacco Smoke | 1994 (Cycle 3) | $225,000 |
| University of California, Davis | Cardiovascular Disease | |
| Crowd Membership and Tobacco Use Among Young Adolescents | 1994 (Cycle 3) | $149,877 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
1993 (Cycle 2)
| Relationship between tobacco use and abruption placentae | 1993 (Cycle 2) | $218,713 |
| University of California, San Diego | Epidemiology | |
| A Metabolic Mechanism of Action of Antiischemic Agents | 1993 (Cycle 2) | $225,000 |
| University of California, Los Angeles | Cardiovascular Disease | |
| Growth Control Pathways in Thyroid Follicular Epithelial Cells | 1993 (Cycle 2) | $224,759 |
| University of California, San Diego | General Biomedical Science | |
| Factors Affecting Smoking Initiation in Young Latina Women | 1993 (Cycle 2) | $149,705 |
| University of California, Los Angeles | Public Health, Public Policy, and Economics | |
| Effects of Cigarette Smoke on Nerve and Blood Vessel Growth | 1993 (Cycle 2) | $224,082 |
| University of California, San Francisco | General Biomedical Science | |
| Diaphragm Structural and Metabolic Changes in Emphysema | 1993 (Cycle 2) | $224,988 |
| University of California, San Diego | Pulmonary Disease | |
| Molecular Analysis of a DNA Repair Function | 1993 (Cycle 2) | $90,030 |
| Salk Institute for Biological Studies | General Biomedical Science | |
| Function In Lung Matrix of a Laminin-Binding Lectin | 1993 (Cycle 2) | $244,977 |
| University of California, San Francisco | Pulmonary Disease | |
| Impact of Nursing Care on Symptom Distress & Quality of Life | 1993 (Cycle 2) | $221,193 |
| University of California, Los Angeles | Public Health, Public Policy, and Economics | |
| Effects of Cigarette Smoking in Low-Dose Zinc Fume Inhalation | 1993 (Cycle 2) | $225,000 |
| University of California, San Francisco | Epidemiology | |
| The tobacco industry and scientific research | 1993 (Cycle 2) | $219,846 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Effects of passive smoking on sudden infant death syndrome | 1993 (Cycle 2) | $74,606 |
| University of California, San Diego | Epidemiology | |
| Tumor Specific Antibodies | 1993 (Cycle 2) | $224,974 |
| University of California, Davis | Cancer | |
| The Role of the Macrophage in Lung Cancer | 1993 (Cycle 2) | $215,007 |
| University of California, Los Angeles | Cancer | |
| Stabilizing the Occlusion in the Dentate Hemimandibulectomy | 1993 (Cycle 2) | $104,037 |
| University of California, San Francisco | General Biomedical Science | |
| Molecular Basis of Lung Cancer Metastasis | 1993 (Cycle 2) | $225,093 |
| University of California, San Francisco | Cancer | |
1992 (Cycle 1)
| Cigarette Smoke Induced Changes in Gene Expression | 1992 (Cycle 1) | $222,046 |
| University of California, Davis | Cancer | |
| Smoking Intervention for Women Seen in Primary Care Practice | 1992 (Cycle 1) | $218,178 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Effects of Passive Smoking on Sudden Infant Death Syndrome | 1992 (Cycle 1) | $149,900 |
| University of California, San Diego | Epidemiology | |
| Smoking-Related Risks for Small Cell Lung Cancer in Women | 1992 (Cycle 1) | $214,066 |
| University of California, Irvine | Epidemiology | |
| Persistent Pulmonary Hypertension & Maternal Smoking | 1992 (Cycle 1) | $232,350 |
| Children's Hospital Oakland Research Institute | Pulmonary Disease | |
| Smoking Prevention for Hispanic Pregnant & Non-pregnant Adolescents | 1992 (Cycle 1) | $217,470 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Characterization of a New Tumor Suppressor Gene | 1992 (Cycle 1) | $200,810 |
| University of California, San Diego | Cancer | |
| Cigarette Smoke Expusure & Antioxidant Activity in Blood | 1992 (Cycle 1) | $74,439 |
| Lawrence Berkeley National Laboratory | General Biomedical Science | |
| Tobacco Use In Pregnancy: Chronic Effects On Blood Flow | 1992 (Cycle 1) | $332,222 |
| Cedars-Sinai Medical Center | General Biomedical Science | |
| Nicotine & The Heart: Potential Link to Sudden Death | 1992 (Cycle 1) | $150,000 |
| University of California, San Francisco | Cardiovascular Disease | |
| NMYC Oncogene Expression in Small Cell Lung Cancer | 1992 (Cycle 1) | $225,000 |
| University of California, Los Angeles | Cancer | |
| Nicotine & Cardiavascular Control During Exercise | 1992 (Cycle 1) | $220,302 |
| University of California, Davis | Cardiovascular Disease | |
| Tumor Models & Radioimmunotherapy of Human Lung Cancers | 1992 (Cycle 1) | $202,062 |
| City of Hope National Medical Center | Cancer | |
| Retinoic Acid Receptor Expression in Human Lung Cancer | 1992 (Cycle 1) | $204,590 |
| University of California, Los Angeles | Cancer | |
| Tobacco Smoke, Benzene, & Mechanisms of Leukemogenesis | 1992 (Cycle 1) | $224,492 |
| University of California, Riverside | Cancer | |
| Smoking-Induced Alteration of the Macrophage NADPH Oxidase | 1992 (Cycle 1) | $76,840 |
| University of California, San Diego | Pulmonary Disease | |
| Diaphragm Cellular & Functional Adaptations to Emphysema | 1992 (Cycle 1) | $135,116 |
| Cedars-Sinai Medical Center | Pulmonary Disease | |
| Family Intervention to Prevent Smoking: Preliminary Studies | 1992 (Cycle 1) | $123,704 |
| Stanford University | Tobacco-Use Prevention and Cessation | |
| Local Cytokine Immunotherapy for Lung Cancer | 1992 (Cycle 1) | $225,000 |
| University of California, Los Angeles | Cancer | |
| Cigarette Smoke Expusure & Antioxidant Activity in Blood | 1992 (Cycle 1) | $260,359 |
| Stanford University | General Biomedical Science | |
| Stem Cell Transplantation for Small & Non-small Cell Lung Cancers | 1992 (Cycle 1) | $174,666 |
| University of California, Los Angeles | Cancer | |
| Effects of Cigarette Smoking on Leukocyte Adhesion Molecules | 1992 (Cycle 1) | $223,015 |
| University of California, San Francisco | General Biomedical Science | |
| Tobacco-Related Carcinogens in Human Epithelial Cells | 1992 (Cycle 1) | $224,999 |
| Lawrence Berkeley National Laboratory | Cancer | |
| Human Mast Cell Proteases: Function & Expression in Smoking-Induced Diseases | 1992 (Cycle 1) | $222,277 |
| University of California, San Diego | General Biomedical Science | |
| Tumor Models & Radioimmunotherapy of Human Lung Cancers | 1992 (Cycle 1) | $12,382 |
| University of Southern California | Cancer | |
| MS Studies of Tobacco -- Specific Adducts with Hemoglobin | 1992 (Cycle 1) | $225,000 |
| University of California, San Francisco | General Biomedical Science | |
| A Smoking Prevention Model for Low Income Minority Youth | 1992 (Cycle 1) | $323,095 |
| Charles R. Drew University of Medicine & Science | Tobacco-Use Prevention and Cessation | |
| Cytokines and Foam Cell Formation | 1992 (Cycle 1) | $321,593 |
| Palo Alto Medical Foundation Research Institute | General Biomedical Science | |
| Release of Pulmonary Peptides: Nicotine & Inflammation | 1992 (Cycle 1) | $223,588 |
| University of California, San Diego | Pulmonary Disease | |
| Factors Required for K-RAS 4B Membrane Association & Activity | 1992 (Cycle 1) | $164,736 |
| Scripps Research Institute | General Biomedical Science | |
| Preclinical Studies of Novel Agents for Lung Cancer | 1992 (Cycle 1) | $225,000 |
| University of California, San Diego | Cancer | |
| The Role of Tobacco Smoke in Multi-Step Carcinogenesis | 1992 (Cycle 1) | $341,730 |
| Childrens Hospital, Los Angeles | Cancer | |
| Studies in Genotoxicity of Tobacco-Related Carcinogens | 1992 (Cycle 1) | $288,000 |
| The Burnham Institute for Medical Research | Cancer | |
| Smoking & COPD: Effects on Cerebral Perfusion & Function | 1992 (Cycle 1) | $292,953 |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | Pulmonary Disease | |
| Sidestream Smoke Effects on Immature Airway Receptors | 1992 (Cycle 1) | $211,744 |
| University of California, Davis | Pulmonary Disease | |
| Tumor Suppressor Gene Mutations in Lung Cancer | 1992 (Cycle 1) | $333,054 |
| University of Southern California | Cancer | |